TGF-beta 1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells


Autoria(s): Gomes, Luciana Rodrigues; Terra, Letícia Ferreira; Mansano, Rosangela Aparecida Wailemann; Labriola, Leticia; Sogayar, Mari Cleide
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

07/11/2013

07/11/2013

2012

Resumo

Background: Metastasis is the main factor responsible for death in breast cancer patients. Matrix metalloproteinases (MMPs) and their inhibitors, known as tissue inhibitors of MMPs (TIMPs), and the membrane-associated MMP inhibitor (RECK), are essential for the metastatic process. We have previously shown a positive correlation between MMPs and their inhibitors expression during breast cancer progression; however, the molecular mechanisms underlying this coordinate regulation remain unknown. In this report, we investigated whether TGF-beta 1 could be a common regulator for MMPs, TIMPs and RECK in human breast cancer cell models. Methods: The mRNA expression levels of TGF-beta isoforms and their receptors were analyzed by qRT-PCR in a panel of five human breast cancer cell lines displaying different degrees of invasiveness and metastatic potential. The highly invasive MDA-MB-231 cell line was treated with different concentrations of recombinant TGF-beta 1 and also with pharmacological inhibitors of p38 MAPK and ERK1/2. The migratory and invasive potential of these treated cells were examined in vitro by transwell assays. Results: In general, TGF-beta 2, T beta RI and T beta RII are over-expressed in more aggressive cells, except for T beta RI, which was also highly expressed in ZR-75-1 cells. In addition, TGF-beta 1-treated MDA-MB-231 cells presented significantly increased mRNA expression of MMP-2, MMP-9, MMP-14, TIMP-2 and RECK. TGF-beta 1 also increased TIMP-2, MMP-2 and MMP-9 protein levels but downregulated RECK expression. Furthermore, we analyzed the involvement of p38 MAPK and ERK1/2, representing two well established Smad-independent pathways, in the proposed mechanism. Inhibition of p38MAPK blocked TGF-beta 1-increased mRNA expression of all MMPs and MMP inhibitors analyzed, and prevented TGF-beta 1 upregulation of TIMP-2 and MMP-2 proteins. Moreover, ERK1/2 inhibition increased RECK and prevented the TGF-beta 1 induction of pro-MMP-9 and TIMP-2 proteins. TGF-beta 1-enhanced migration and invasion capacities were blocked by p38MAPK, ERK1/2 and MMP inhibitors. Conclusion: Altogether, our results support that TGF-beta 1 modulates the mRNA and protein levels of MMPs (MMP-2 and MMP-9) as much as their inhibitors (TIMP-2 and RECK). Therefore, this cytokine plays a crucial role in breast cancer progression by modulating key elements of ECM homeostasis control. Thus, although the complexity of this signaling network, TGF-beta 1 still remains a promising target for breast cancer treatment.

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)

Conselho Nacional de Pesquisa (CNPq)

Conselho Nacional de Pesquisa (CNPq)

Financiadora de Estudos e Projetos (FINEP)

Financiadora de Estudos e Projetos (FINEP)

Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)

Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)

Banco Nacional de Desenvolvimento Social e Economico (BNDES - FUNTEC)

Banco Nacional de Desenvolvimento Social e Economico (BNDES FUNTEC)

Departamento de Ciencia e Tecnologia em Saude - Ministerio da saude (DECIT-MS)

Departamento de Ciencia e Tecnologia em Saude Ministerio da saude (DECITMS)

Ministerio de Ciencia e Tecnologia (MCT)

Ministerio de Ciencia e Tecnologia (MCT)

Identificador

BMC CANCER, LONDON, v. 12, n. 6, supl., Part 3, pp. 594-606, 43466, 2012

1471-2407

http://www.producao.usp.br/handle/BDPI/43313

10.1186/1471-2407-12-26

http://dx.doi.org/10.1186/1471-2407-12-26

Idioma(s)

eng

Publicador

BIOMED CENTRAL LTD

LONDON

Relação

BMC CANCER

Direitos

openAccess

Copyright BIOMED CENTRAL LTD

Palavras-Chave #GROWTH-FACTOR-BETA #MATRIX-METALLOPROTEINASE EXPRESSION #EPITHELIAL-MESENCHYMAL TRANSITION #TGF-BETA #1-MATRIX METALLOPROTEINASE #TISSUE INHIBITOR #UP-REGULATION #METASTASIS #PROGRESSION #MATRIX-METALLOPROTEINASE-9 #ONCOLOGY
Tipo

article

original article

publishedVersion